CARISMA Therapeutics Appoints Richard Morris as Chief Financial Officer

June 8, 2021

PHILADELPHIA, June 8, 2021 — CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced today that Richard Morris has been appointed Chief Financial Officer (CFO). For full press release click here.